SCHEMBL7955784

SCHEMBL7955784

CC[C@@H](F)c1cc(N2CCN(CCO)CC2)cc(-c2ccccc2C(F)(F)F)c1Cl

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.38
TP53 P04637 2/20 0.37
MAPK1 P28482 2/20 0.37
DRD2 P14416 1/20 0.36
DRD3 P35462 1/20 0.36
NPSR1 Q6W5P4 1/20 0.35
CACNA1G O43497 1/20 0.35
HRH4 Q9H3N8 1/20 0.35
ADRA1D P25100 1/20 0.35
ADRA1A P35348 1/20 0.35
ADRA1B P35368 1/20 0.35
GAA P10253 1/20 0.35
CYP1A2 P05177 3/20 0.34
CYP2C19 P33261 3/20 0.34
CYP3A4 P08684 2/20 0.34
CYP2D6 P10635 2/20 0.34
SIGMAR1 Q99720 2/20 0.34
KCNK2 O95069 1/20 0.34
USP2 O75604 1/20 0.34
TSHR P16473 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7584122 1.00 MAPT (0.38) MAPTTP53MAPK1DRD2DRD3
SCHEMBL7590011 0.90 CNR2 (0.41) MAPTTP53CACNA1GADRA1DADRA1A
SCHEMBL7587203 0.90 CNR2 (0.41) MAPTTP53CACNA1GADRA1DADRA1A
SCHEMBL7583679 0.88 DRD2 (0.44) MAPTDRD2DRD3NPSR1HRH4
SCHEMBL7582205 0.87 DRD2 (0.38) MAPTTP53MAPK1DRD2DRD3
SCHEMBL7587432 0.86 MAPT (0.39) MAPTDRD2DRD3NPSR1HRH4
SCHEMBL7589752 0.84 DRD2 (0.36) MAPTDRD2DRD3NPSR1HRH4
Hydrochloric Acid SCHEMBL7585021 0.83 DRD2 (0.35) MAPTDRD2DRD3NPSR1HRH4
Hydrochloric Acid SCHEMBL7584884 0.83 DRD2 (0.35) MAPTDRD2DRD3NPSR1HRH4
SCHEMBL7585740 0.79 DRD2 (0.44) DRD2DRD3ADRA1AGAASIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6281214-B1 USEFUL FOR TREATING AND AMELIORATING MENTAL DISORDERS EISAI CO., LTD (JP) 2001-08-28 US disclosed
EP-0675118-A2 Biphenylderivatives, process for their preparation and their use as medicaments Eisai Co., Ltd. (JP) 1995-10-04 EP disclosed